Consistent with this, combined inhibition of BTK with either rapamycin or U0126, which resulted in essentially full reversal of anti-IgM-induced PDCD4 down-regulation, was very effective at repressing MYC induction in CLL cells. The gene discussed is PDCD4; the disease is B-cell chronic lymphocytic leukemia.